2026-04-26T23:29:38Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/187142024-09-21T22:10:48Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927

00925njm 22002777a 4500 dc Sanz-Cánovas, Jaime author López-Sampalo, Almudena author Cobos-Palacios, Lidia author Ricci, Michele author Hernández-Negrín, Halbert author Mancebo-Sevilla, Juan José author Álvarez-Recio, Elena author López-Carmona, María Dolores author Pérez-Belmonte, Luis Miguel author Gómez-Huelgas, Ricardo author Bernal-López, Maria Rosa author 2022-07-16 The life expectancy of the population is increasing worldwide due to improvements in the prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 diabetes mellitus (T2DM) in the elderly. Sarcopenia and frailty are also frequently present in aging. These three entities share common mechanisms such as insulin resistance, chronic inflammation, and mitochondrial dysfunction. The coexistence of these situations worsens the prognosis of elderly patients. In this paper, we review the main measures for the prevention and management of sarcopenia and/or frailty in elderly patients with T2DM. http://hdl.handle.net/10668/21084 http://hdl.handle.net/20.500.12105/18714 35886528 10.3390/ijerph19148677 1660-4601 International journal of environmental research and public health Elderly Frailty Sarcopenia Type 2 diabetes mellitus Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia.